348 related articles for article (PubMed ID: 26716991)
1. Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats.
Favaro VM; Yonamine M; Soares JC; Oliveira MG
PLoS One; 2015; 10(12):e0145840. PubMed ID: 26716991
[TBL] [Abstract][Full Text] [Related]
2. Chronic intermittent exposure to ayahuasca during aging does not affect memory in mice.
Correa-Netto NF; Coelho LS; Galfano GS; Nishide F; Tamura F; Shimizu MK; Santos JG; Linardi A
Braz J Med Biol Res; 2017 Jun; 50(7):e6037. PubMed ID: 28591380
[TBL] [Abstract][Full Text] [Related]
3. Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.
Pic-Taylor A; da Motta LG; de Morais JA; Junior WM; Santos Ade F; Campos LA; Mortari MR; von Zuben MV; Caldas ED
Behav Processes; 2015 Sep; 118():102-10. PubMed ID: 26049017
[TBL] [Abstract][Full Text] [Related]
4. An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice.
Correa-Netto NF; Masukawa MY; Nishide F; Galfano GS; Tamura F; Shimizo MK; Marcato MP; Santos JG; Linardi A
Braz J Med Biol Res; 2017 Jun; 50(7):e6036. PubMed ID: 28591379
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
McKenna DJ; Towers GH; Abbott F
J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
[TBL] [Abstract][Full Text] [Related]
6. Ayahuasca Alters Structural Parameters of the Rat Aorta.
Pitol DL; Siéssere S; Dos Santos RG; Rosa ML; Hallak JE; Scalize PH; Pereira BF; Iyomasa MM; Semprini M; Riba J; Regalo SC
J Cardiovasc Pharmacol; 2015 Jul; 66(1):58-62. PubMed ID: 25714595
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
[TBL] [Abstract][Full Text] [Related]
10. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
[TBL] [Abstract][Full Text] [Related]
11. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
Heise CW; Brooks DE
J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
[TBL] [Abstract][Full Text] [Related]
12. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
[TBL] [Abstract][Full Text] [Related]
13. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
[TBL] [Abstract][Full Text] [Related]
14. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
15. Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture.
Freedland CS; Mansbach RS
Drug Alcohol Depend; 1999 May; 54(3):183-94. PubMed ID: 10372792
[TBL] [Abstract][Full Text] [Related]
16. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
[TBL] [Abstract][Full Text] [Related]
17. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
[TBL] [Abstract][Full Text] [Related]
18. Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice.
Almeida CAF; Pereira-Junior AA; Rangel JG; Pereira BP; Costa KCM; Bruno V; Silveira GO; Ceron CS; Yonamine M; Camarini R; Garcia RCT; Marcourakis T; Torres LH
Behav Brain Res; 2022 Jan; 416():113546. PubMed ID: 34437939
[TBL] [Abstract][Full Text] [Related]
19. Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users.
Mello SM; Soubhia PC; Silveira G; Corrêa-Neto NF; Lanaro R; Costa JL; Linardi A
J Psychoactive Drugs; 2019; 51(1):3-11. PubMed ID: 30582439
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.
Bouso JC; Fábregas JM; Antonijoan RM; Rodríguez-Fornells A; Riba J
Psychopharmacology (Berl); 2013 Dec; 230(3):415-24. PubMed ID: 23793226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
